“…SPEMD was first reported in schizophrenia patients in 1908 by Diefendorf and Dodge (Diefendorf & Dodge, 1908); because of its impact on oculomotor research, this paper gave rise to the current centenary special issue. SPEMD has since been viewed as one of the most promising candidate endophenotypes to assist in our search for schizophrenia genes (Erlenmeyer-Kimling & Cornblatt, 1987; Holzman, 1987; Iacono, 1983, 1988, 1998; Iacono & Grove, 1993; Lee & Williams, 2000; Siever & Coursey, 1985; Siever, Coursey, Alterman, Buchsbaum, & Murphy, 1982; Venables, 1991). In addition to SPEMD, several other forms of eye movement dysfunction (EMD) have been implicated as candidate endophenotypes of schizophrenia (e.g., Broerse, Holthausen, van den Bosch, & den Boer, 2001; Calkins & Iacono, 2000; Clementz, 1998; Curtis, Calkins, & Iacono, 2001).…”